EMEA
-
UK utility eyes five or 10 year green notes in Aussie dollars -
French bank opts for AT1 while Lloyds progresses senior funding plan
-
◆ Pharma company prints 5.3, 10 and 15 year bonds ◆ Biggest domestic corporate deal in Swiss francs this year ◆ Roche pushes pricing and size in shorter tranches
-
OATs and OLOs could weaken further versus Bunds while southern European countries and EU continue to paint a positive picture
-
September redemption cash and shortage of supply support investor demand
-
Uncertainty looms large as presidential race far from clear and budget negotiations potentially ‘highly challenging’
-
M&A could be much needed shot in the arm but dollars expected to dominate
-
AbbVie and Alphabet drive dollar supply towards its busiest August since 2020
-
Private placements may have hung around much longer than first expected but their dominance may be at an end
-
Mizuho, HSBC, StanChart and SMBC ran the first syndication for the KIA since 1999
-
◆ Orbit prints 15 year trade after one day of marketing ◆ Demand peaks at five times the deal size ◆ Small new issue premium spotted
-
Sukuk volumes much slimmer this year
